|
1
|
Kufe DW: Functional targeting of the MUC1
oncogene in human cancers. Cancer Biol Ther. 8:1197–1203. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nath S and Mukherjee P: MUC1: A
multifaceted oncoprotein with a key role in cancer progression.
Trends Mol Med. 20:332–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kufe DW: Targeting the human MUC1
oncoprotein: A tale of two proteins. Cancer Biol Ther. 7:81–84.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang L, Chen D, Liu D, Yin L, Kharbanda S
and Kufe D: MUC1 oncoprotein blocks glycogen synthase kinase
3beta-mediated phosphorylation and degradation of beta-catenin.
Cancer Res. 65:10413–10422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Kuwahara H, Ren J, Wen G and Kufe D:
The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1
carcinoma-associated antigen with GSK3 beta and beta-catenin. J
Biol Chem. 276:6061–6064. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pandey P, Kharbanda S and Kufe D:
Association of the DF3/MUC1 breast cancer antigen with Grb2 and the
Sos/Ras exchange protein. Cancer Res. 55:4000–4003. 1995.PubMed/NCBI
|
|
7
|
Lau SK, Shields DJ, Murphy EA,
Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM,
Stupack DG, et al: EGFR-mediated carcinoma cell metastasis mediated
by integrin αvβ5 depends on activation of c-Src and cleavage of
MUC1. PLoS One. 7:e367532012. View Article : Google Scholar
|
|
8
|
Schroeder JA, Thompson MC, Gardner MM and
Gendler SJ: Transgenic MUC1 interacts with epidermal growth factor
receptor and correlates with mitogen-activated protein kinase
activation in the mouse mammary gland. J Biol Chem.
276:13057–13064. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmad R, Raina D, Trivedi V, Ren J, Rajabi
H, Kharbanda S and Kufe D: MUC1 oncoprotein activates the IkappaB
kinase beta complex and constitutive NF-kappaB signalling. Nat Cell
Biol. 9:1419–1427. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahmad R, Raina D, Joshi MD, Kawano T, Ren
J, Kharbanda S and Kufe D: MUC1-C oncoprotein functions as a direct
activator of the nuclear factor-kappaB p65 transcription factor.
Cancer Res. 69:7013–7021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh PK, Behrens ME, Eggers JP, Cerny RL,
Bailey JM, Shanmugam K, Gendler S, Bennett EP and Hollingsworth MA:
Phosphorylation of MUC1 by Met modulates interaction with p53 and
MMP1 expression. J Biol Chem. 283:26985–26995. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei X, Xu H and Kufe D: Human mucin 1
oncoprotein represses transcription of the p53 tumor suppressor
gene. Cancer Res. 67:1853–1858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Banerjee S, Mujumdar N, Dudeja V,
Mackenzie T, Krosch TK, Sangwan V, Vickers SM and Saluja AK: MUC1c
regulates cell survival in pancreatic cancer by preventing
lysosomal permeabilization. PLoS One. 7:e430202012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren J, Bharti A, Raina D, Chen W, Ahmad R
and Kufe D: MUC1 oncoprotein is targeted to mitochondria by
heregulin-induced activation of c-Src and the molecular chaperone
HSP90. Oncogene. 25:20–31. 2006.
|
|
15
|
Agata N, Ahmad R, Kawano T, Raina D,
Kharbanda S and Kufe D: MUC1 oncoprotein blocks death
receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
Cancer Res. 68:6136–6144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yonemitsu Y, Imazeki F, Chiba T, Fukai K,
Nagai Y, Miyagi S, Arai M, Aoki R, Miyazaki M, Nakatani Y, Iwama A
and Yokosuka O: Distinct expression of polycomb group proteins EZH2
and BMI1 in hepatocellular carcinoma. Hum Pathol. 40:1304–1311.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Capurro M, Wanless IR, Sherman M, Deboer
G, Shi W, Miyoshi E and Filmus J: Glypican-3: a novel serum and
histochemical marker for hepatocellular carcinoma.
Gastroenterology. 125:89–97. 2013. View Article : Google Scholar
|
|
18
|
Jego G, Hazoumé A, Seigneuric R and
Garrido C: Targeting heat shock proteins in cancer. Cancer Lett.
332:275–285. 2013. View Article : Google Scholar
|
|
19
|
Oikawa T, Kamiya A, Zeniya M, Chikada H,
Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW,
Reid LM and Nakauchi H: Sal-like protein 4 (SALL4), a stem cell
biomarker in liver cancers. Hepatology. 57:1469–1483. 2013.
View Article : Google Scholar
|
|
20
|
Bozkaya G, Korhan P, Cokaklı M, Erdal E,
Sağol O, Karademir S, Korch C and Atabey N: Cooperative interaction
of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Mol
Cancer. 11:642012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan SF, Li KZ, Wang L, Dou KF, Yan Z, Han
W and Zhang YQ: Expression of MUC1 and its significance in
hepatocellular and cholangiocarcinoma tissue. World J
Gastroenterol. 11:4661–4666. 2005.PubMed/NCBI
|
|
22
|
Gad A, Tanaka E, Matsumoto A, Wahab MA,
Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T,
et al: Assessment of KL-6 as a tumor marker in patients with
hepato-cellular carcinoma. World J Gastroenterol. 11:6607–6612.
2005. View Article : Google Scholar
|
|
23
|
Li QS, Wang FL, Liu GM, Yuan HY, Chen TX,
Wang J, Xie F, Zhai RP, Wang F, Guo YY, et al: Impact of Mucin1
knockdown on the phenotypic characteristics of the human
hepatocellular carcinoma cell line SMMC-7721. Oncol Rep.
31:2811–2819. 2014.PubMed/NCBI
|
|
24
|
Wang FL, Li QS, Ni WH, Fang F, Sun XX, Xie
F, Wang J, Wang F, Gao SJ and Tai GX: Expression of human
full-length MUC1 inhibits the proliferation and migration of a B16
mouse melanoma cell line. Oncol Rep. 30:260–268. 2013.PubMed/NCBI
|
|
25
|
Castorina A and Giunta S: Mucin 1 (MUC1)
signalling contributes to increase the resistance to cell death in
human bronchial epithelial cells exposed to nickel acetate.
Biometals. 27:1149–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin L, Kufe T, Avigan D and Kufe D:
Targeting MUC1-C is synergistic with bortezomib in downregulating
TIGAR and inducing ROS-mediated myeloma cell death. Blood.
123:2997–3006. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Q, Li D, Ren J, Li C and Xiao Z: MUC1
activates JNK1 and inhibits apoptosis under genotoxic stress.
Biochem Biophys Res Commun. 440:179–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Costa NR, Paulo P, Caffrey T,
Hollingsworth MA and Santos-Silva F: Impact of MUC1 mucin
downregulation in the phenotypic characteristics of MKN45 gastric
carcinoma cell line. PloS One. 6:e269702011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zimmermann KC and Green DR: How cells die:
Apoptosis pathways. J Allergy Clin Immunol. 108(4 Suppl): S99–S103.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Srinivas G, Kusumakumary P, Nair MK,
Panicker KR and Pillai MR: Mutant p53 protein, Bcl-2/Bax ratios and
apoptosis in paediatric acute lymphoblastic leukaemia. J Cancer Res
Clin Oncol. 126:62–67. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmad R, Alam M, Rajabi H and Kufe D: The
MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX
protein and blocks BAX function. J Biol Chem. 287:20866–20875.
2012. View Article : Google Scholar : PubMed/NCBI
|
